📋 Brown Bag Medication Review Simulator

Bring the Actual Bottles — Why the Brown Bag Review Exists

The "brown bag" medication review gets its name from the simple instruction given to patients: put every medication you have at home into a bag and bring it to your appointment — prescription bottles, over-the-counter boxes, vitamins, herbal supplements, eye drops, inhalers, everything. This deceptively simple act routinely uncovers a gap between the medical record and reality that chart review and verbal recall alone cannot close.

• ~50%: Patients with ≥1 discrepancy (commonly reported in brown bag studies)
• 8–12: Avg. containers per elderly patient (Rx, OTC, and supplements combined)
• Lower: Recall accuracy vs. containers (self-report alone underperforms)
• 1990s: Concept in practice since (pharmacy & geriatric medicine literature)

Why containers beat memory and the chart

Three sources of truth exist for a patient's medication regimen, and they frequently disagree:

• The medical record — what a clinician prescribed and documented, which may be stale if refills, dose changes, or stops were never captured • Patient recall — subject to memory lapses, especially with multiple prescribers, changing regimens, or cognitive decline • The actual containers — physical evidence of what was dispensed, when, and how much has been used

The brown bag method treats the physical containers as the most objective anchor available in an outpatient setting. It does not replace the chart or the interview — it triangulates against them, surfacing exactly where the three sources diverge.

A brown bag review is not about catching the patient in an error. It is a structured way to make an invisible gap visible — most discrepancies originate from fragmented care across multiple prescribers and pharmacies, not from anything the patient did wrong.

What counts as "everything"

A complete brown bag includes categories patients often assume do not matter enough to bring:

• Prescription medications, including ones prescribed by specialists the primary reviewer may not know about • Over-the-counter drugs — analgesics, antihistamines, laxatives, sleep aids • Vitamins, minerals, and herbal or dietary supplements, which can interact with prescription drugs • Topicals, eye drops, inhalers, and as-needed (PRN) medications that are easy to omit from a verbal history • Discontinued or expired containers still sitting in a cabinet, which turn out to be some of the most clinically important items in the bag

What the Bag Reveals That the Chart Does Not

Laying the actual containers next to the recorded medication list is where the brown bag review earns its value. Three discrepancy patterns recur so often that they are considered hallmark findings: medications the record says were stopped but the patient is still taking, duplicate therapies prescribed independently by different clinicians, and medications the patient stopped on their own without telling anyone.

• Common: Discontinued-but-still-taken (top recurring discrepancy type)
• Frequent: Duplicate therapy from 2+ prescribers (especially with specialist co-management)
• Frequent: Self-discontinued, unreported (often due to side effects or cost)
• Majority: Discrepancies caught only by containers (vs. interview-only reconciliation)

Three hallmark discrepancy patterns

• Discontinued-but-still-taken: a clinician stopped a drug (e.g., after a lab result or side effect), documented the stop, but the patient never received or absorbed that instruction clearly and kept refilling and taking it.

• Duplicate therapy: two prescribers — say a primary care physician and a cardiologist — each prescribe a drug from the same class, sometimes the exact same drug at a different dose, without visibility into what the other ordered. The patient ends up with two bottles of a similar medication and may be taking both.

• Self-discontinued, unreported: the patient stopped taking a medication because of side effects, cost, or simply feeling it was not needed, but never mentioned this at a visit — so the chart still lists it as active.

None of these three patterns are reliably caught by asking "are you taking your medications as prescribed?" — patients often answer yes in good faith while describing a regimen that does not match either the bottles or the chart.

Why fragmented care drives these gaps

Discrepancies cluster around care transitions and multiple prescribers: a hospital discharge that changes a home regimen, a specialist adjusting a drug the primary care team also manages, or a pharmacy switch that breaks the feedback loop of refill reminders. Without a single unified view of the medication list across every prescriber and pharmacy, small unsynchronized changes accumulate silently until a brown bag review lines every container up side by side against what is documented.

Reading Fill Dates and Pill Counts Like a Usage Log

Every prescription bottle carries a quiet audit trail: the fill date printed on the label and the number of pills remaining. Comparing how many days have passed since the fill date against how many doses should have been consumed at the prescribed frequency turns a static container into objective evidence of real-world adherence — evidence that does not depend on the patient accurately remembering or reporting their own behavior.

• Key check: Expected vs. actual pill count (reveals over- or under-use)
• Key check: Days since fill vs. days supply (flags late or early refills)
• Lower: Self-report only, adherence accuracy (vs. container-based estimate)
• Higher: Container evidence, adherence accuracy (objective, not memory-dependent)

The pill-count arithmetic

For a bottle filled with a 30-day supply, prescribed once daily: if the fill date was 20 days ago, roughly 10 pills should remain. A bottle with 25 pills remaining after 20 days suggests under-use — doses being skipped or delayed. A bottle nearly empty after only 5 days suggests over-use, or that the patient is taking more than prescribed, or taking a second, overlapping supply.

This arithmetic is simple, but it is something no interview question reliably reconstructs, because patients rarely track exact dates and counts mentally the way a bottle passively records them.

Why this evidence outperforms self-report

Self-report is shaped by recall bias, social desirability (wanting to appear adherent to the clinician), and the simple difficulty of tracking a multi-drug regimen day to day. The physical container sidesteps all three: it does not care what the patient remembers or wants to report, it simply reflects what has physically left the bottle. A reviewer combining fill date, days supply, and remaining count gets a usage estimate that is far closer to ground truth than "yes, I take it every day" — without requiring any additional testing or lab work.

Objective container evidence is especially valuable for medications where under- or over-use has serious consequences — anticoagulants, insulin, and antihypertensives among them — where a pill count discrepancy can flag a safety issue before it becomes an adverse event.

Two Distinct Findings, Two Distinct Concerns

Among the containers that end up on the table, two categories of finding recur constantly: medications that have simply expired, sitting unused or partially used past their labeled date, and medications the patient was explicitly told to stop but continued taking anyway. Both are common. Both matter — but for different reasons, and each calls for a different conversation with the patient.

• Common: Expired containers found per review (sitting in home cabinets unused)
• Common: Discontinued drugs still taken (instruction did not translate to behavior)
• Potency/purity: Safety concern for expired meds (reduced efficacy, rarely acute toxicity)
• Active risk: Safety concern for discontinued meds (drug may now be contraindicated)

Expired medications — a potency and clarity issue

Most expired oral medications gradually lose potency rather than becoming acutely dangerous, but an expired bottle in the bag signals something important regardless: either the patient is taking a drug that may no longer be fully effective, or the bottle represents a supply that was never finished and is now cluttering the regimen and the patient's understanding of what is "active." Either way, it needs to be addressed and cleared — not silently left in the cabinet to potentially be taken again later by mistake.

Discontinued-but-continued — an active safety concern

A medication the patient was told to stop but kept taking is a different order of problem: the discontinuation usually happened for a reason — a drug interaction, an adverse effect, a lab abnormality, or a determination that the drug was no longer indicated. Continuing to take it means that original reason is still live. This is the finding most likely to require immediate clinical attention rather than simple list cleanup, and it is exactly the kind of gap a chart review or brief interview is least likely to catch on its own.

Distinguishing "expired and unused" from "discontinued but still being taken" during the review changes what happens next — one typically prompts safe disposal and list cleanup, the other prompts a direct clinical conversation about why the drug is still being taken and whether it needs to stop now.

From Bag to Corrected List — Reconciliation

The brown bag review is only valuable if its findings are translated back into an updated, accurate medication list. Reconciliation means walking through every discrepancy uncovered — the duplicate, the discontinued-but-continued, the self-stopped, the expired — and resolving each one explicitly, then updating the record so it reflects what the patient is actually taking, not what was last documented.

• Most: Discrepancies requiring list update (once identified during review)
• Many: Discrepancies requiring patient education (why a drug was stopped, or should be)
• Improved: List accuracy after reconciliation (closes chart-vs-reality gap)
• Each visit: Recommended review frequency (or with any new prescriber/pharmacy)

The reconciliation walkthrough

For each container that did not match the recorded list, reconciliation follows the same basic pattern:

1. Confirm what the patient is actually taking and how, using the container as the anchor 2. Determine why the discrepancy exists — was it a communication gap, a duplicate prescription, a side effect, or a deliberate patient decision 3. Decide the clinically correct path forward — resume documentation as-is, stop the medication for real, consolidate duplicates, or address a safety concern directly 4. Update the official medication list to match reality, and explain the change to the patient so the two stay aligned going forward

Why this closes a gap self-report cannot

A medication list built from prescribing records alone will always drift from what a patient is actually taking, because prescribing records capture intent at the moment of the prescription, not ongoing behavior. A brown bag review, repeated periodically, re-anchors the list to reality each time — catching drift before it compounds into duplicate therapies, missed safety signals, or a patient continuing a medication that should have stopped months earlier.

The core lesson of the brown bag review: a medication list is only as accurate as its last physical verification. Chart review and interview are necessary but not sufficient — periodically putting the actual containers on the table remains one of the simplest, lowest-cost ways to catch what both miss.